Publications
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities2022 | Faculty of Medicine in Hradec Králové
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publication without faculty affiliation
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publication without faculty affiliation
- Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators2019 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Faculty of Pharmacy in Hradec Králové
- A-agents, misleadingly known as "Novichoks": a narrative review2023 | Faculty of Pharmacy in Hradec Králové
Loading network view...
